SFDA Cancels the MDNR Procedure

About the Author

Regulatory Editor

Published by regulatory affairs team in PharmaKnowl, Riyadh office.

The SFDA has just announced a new update in the registration process of medical devices . It states that the full technical file assessment TFA will become mandatory on the low-risk medical devices (non-measuring and non-sterile). This time, they officially defined the death date of the current listing process which is simple, fast, and with low SFDA fees. We summarize the announcement in the following points:

  • New and renewal requests on the current procedure will end by 27/9/2022.
  • Any upcoming approvals under the current procedure will only receive a one-year validity certificate.  
  • Currently approved low-risk devices (non-sterile, non-measuring) will be valid till their expiry date
  • From 27/9/2022, such devices must fulfil MDMA requirements.
  • Saudi Authorized representative is a required for all products (low and high-risk).

In summary, companies must be ready to switch to the new MDMA procedure for all types of medical devices.

Read More:

About the Author

Regulatory Editor

Published by regulatory affairs team in PharmaKnowl, Riyadh office.

Services

Events

Have Questions? Lets Connect..

Contact us to schedule a call, request details, or get a tailored proposal.